Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 30, 2026 08:55 ET | Source: JBS USA Food Company

JBS USA Food Company Holdings Announces Cash Tender Offers for Up to $1,000.0 Million Combined Aggregate Principal Amount of Its 6.750% Senior Notes Due 2034 and 5.950% Senior Notes Due 2035

GREELEY, Colo., March 30, 2026 (GLOBE NEWSWIRE) -- JBS USA Food Company Holdings announced today the commencement of tender offers (the “Tender Offers”) to purchase for cash a combined aggregate...
March 25, 2026 16:30 ET | Source: Apollo Global Management, Inc.

Apollo Prices Offering of Senior Notes

NEW YORK, March 25, 2026 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) (the “Issuer” and, together with its consolidated subsidiaries, “Apollo”) today announced that it has priced...
March 17, 2026 09:35 ET | Source: Mizuho Americas

Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

Mizuho wins Best Bank for Corporate Banking in the U.S. Mizuho also wins Best Bank for Coverage for Corporates in the U.S. and Best Bank for Ease of Doing Business for Corporates in the U.S. for...
March 10, 2026 14:00 ET | Source: Medline Inc.

Medline Inc. announces closing of secondary offering of Class A common stock and full exercise of underwriters’ option to purchase additional shares

NORTHFIELD, Ill., March 10, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today that it has closed its secondary offering of 86,250,000 shares of Medline Inc.’s Class A...
March 09, 2026 07:05 ET | Source: Relmada Therapeutics

Relmada Therapeutics Announces Oversubscribed $160.0 Million Private Placement Financing

CORAL GABLES, Fla., March 09, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies...
March 04, 2026 20:00 ET | Source: Medline Inc.

Medline Inc. announces pricing of secondary offering of class A common stock

NORTHFIELD, Ill., March 04, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (Nasdaq: MDLN) (“Medline”) announced today the pricing of a previously announced secondary offering of 75,000,000 shares of Medline...
March 03, 2026 16:05 ET | Source: LifeMD, Inc.

LifeMD to Participate in Two Investor Conferences During March

NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following...
March 02, 2026 07:30 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

WAYNE, Pa., March 02, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...
February 27, 2026 08:24 ET | Source: Fairfax Financial Holdings Limited

Fairfax Completes C$650 Million Senior Notes Offering

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Fairfax Financial Holdings Limited (“Fairfax”) (TSX: FFH and FFH.U)...
February 25, 2026 19:57 ET | Source: Palvella Therapeutics Inc.

Palvella Therapeutics Announces Pricing of Upsized Public Offering

WAYNE, Pa., Feb. 25, 2026 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc. (“Palvella”) (Nasdaq: PVLA), a clinical-stage biopharmaceutical company focused on developing and commercializing novel...